Option Care Health (OPCH)

Its services cover a broad range of infusion needs, including anti-infective therapy, nutrition support, immunoglobulin treatment, therapies for chronic inflammatory and neurological conditions, bleeding disorder treatments, and medications used in heart failure and other specialty areas. Option Care Health combines clinical pharmacy operations, nursing support, care coordination, and patient monitoring to help administer therapies that can require careful dosing, storage, handling, and follow-up.

The company operates as a single infusion services business, with a national platform that includes infusion pharmacies, ambulatory infusion suites, and home-based care capabilities. This model places Option Care Health within a healthcare market shaped by efforts to move appropriate treatments into lower-cost care settings while maintaining clinical oversight and patient convenience.

For investors, OPCH represents exposure to specialty pharmacy, home healthcare, and the broader shift toward site-of-care optimization in the US medical system. Its performance is influenced by referral volumes, reimbursement arrangements, drug mix, labor availability, relationships with healthcare providers, and demand for complex therapies that can be administered outside hospitals.